Ionis Pharmaceuticals, Inc. - stock earnings
IONS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / -1.0279000000 | - | - / 145.2 million | - |
IONS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -9.3 million USD | 324.5 million USD |
| 2023Q3 | -147.0 million USD | 144.0 million USD |
| 2023Q2 | -85.0 million USD | 188.0 million USD |
| 2023Q1 | -124.0 million USD | 131.0 million USD |
| 2022Q4 | -52.0 million USD | 152.0 million USD |
| 2022Q3 | -47.0 million USD | 159.8 million USD |
| 2022Q2 | -105.1 million USD | 133.8 million USD |
| 2022Q1 | -65.2 million USD | 141.9 million USD |
| 2021Q4 | 225.0 million USD | 440.0 million USD |
| 2021Q3 | -82.5 million USD | 133.1 million USD |
| 2021Q2 | -80.9 million USD | 125.8 million USD |
| 2021Q1 | -89.9 million USD | 111.6 million USD |
| 2020Q4 | -340.0 million USD | 290.0 million USD |
| 2020Q3 | -30.9 million USD | 160.1 million USD |
| 2020Q2 | -31.8 million USD | 145.5 million USD |
| 2020Q1 | -48.2 million USD | 133.4 million USD |
| 2019Q4 | 184.0 million USD | 494.0 million USD |
| 2019Q3 | 26.2 million USD | 167.9 million USD |
| 2019Q2 | -1.0 million USD | 164.0 million USD |
| 2019Q1 | 84.4 million USD | 297.2 million USD |
| 2018Q4 | 320.1 million USD | 192.1 million USD |
| 2018Q3 | -4.6 million USD | 145.4 million USD |
| 2018Q2 | -40.4 million USD | 117.7 million USD |
| 2018Q1 | -1.4 million USD | 144.4 million USD |
| 2017Q4 | 2.7 million USD | 172.3 million USD |
| 2017Q3 | -976000 USD | 120.9 million USD |
| 2017Q2 | -11.2 million USD | 104.2 million USD |
| 2017Q1 | 3.5 million USD | 110.3 million USD |
| 2016Q4 | 25.9 million USD | 160.3 million USD |
| 2016Q3 | 7.4 million USD | 110.9 million USD |
| 2016Q2 | -56.9 million USD | 38.5 million USD |
| 2016Q1 | -62.9 million USD | 36.9 million USD |
| 2015Q4 | -71.4 million USD | 51.6 million USD |
| 2015Q3 | -35.8 million USD | 49.1 million USD |
| 2015Q2 | 35.6 million USD | 120.4 million USD |
| 2015Q1 | -16.7 million USD | 62.6 million USD |
| 2014Q4 | 31.1 million USD | 84.9 million USD |
| 2014Q3 | -26.7 million USD | 44.1 million USD |
| 2014Q2 | -12.1 million USD | 57.1 million USD |
| 2014Q1 | -31.3 million USD | 28.2 million USD |
| 2013Q4 | -24.3 million USD | 42.2 million USD |
| 2013Q3 | -24.6 million USD | 23.6 million USD |
| 2013Q2 | -10.1 million USD | 38.1 million USD |
| 2013Q1 | -1.7 million USD | 43.4 million USD |
| 2012Q4 | -2.6 million USD | 19.9 million USD |
| 2012Q3 | -37.6 million USD | 11.6 million USD |
| 2012Q2 | -1.2 million USD | 47.3 million USD |
| 2012Q1 | -24.0 million USD | 23.2 million USD |
| 2011Q4 | -20.0 million USD | 32.4 million USD |
| 2011Q3 | -26.9 million USD | 20.7 million USD |
| 2011Q2 | -17.9 million USD | 24.8 million USD |
| 2011Q1 | -20.0 million USD | 21.1 million USD |
| 2010Q4 | -14.0 million USD | 26.4 million USD |
| 2010Q3 | -12.5 million USD | 28.6 million USD |
| 2010Q2 | -25.2 million USD | 23.5 million USD |
| 2010Q1 | -9.7 million USD | 29.9 million USD |
| 2009Q4 | -7.0 million USD | 32.3 million USD |
| 2009Q3 | -6.9 million USD | 26.8 million USD |
| 2009Q2 | -2.9 million USD | 31.0 million USD |
| 2009Q1 | 171.8 million USD | 31.6 million USD |
| 2008Q4 | -8.7 million USD | 20.7 million USD |
| 2008Q3 | 3.2 million USD | 32.2 million USD |
| 2008Q2 | -2.2 million USD | 33.0 million USD |
| 2008Q1 | -4.3 million USD | 21.4 million USD |
| 2007Q4 | -7.0 million USD | 24.7 million USD |
| 2007Q3 | 20.0 million USD | 38.6 million USD |
| 2007Q2 | -11.0 million USD | 3.8 million USD |
| 2007Q1 | -13.0 million USD | 2.5 million USD |
| 2006Q4 | -14.1 million USD | 11.9 million USD |
| 2006Q3 | -12.1 million USD | 3.3 million USD |
| 2006Q2 | -2.2 million USD | 4.4 million USD |
| 2006Q1 | -17.5 million USD | 5.0 million USD |
| 2005Q4 | -7.9 million USD | 14.6 million USD |
| 2005Q3 | -15.2 million USD | 7.5 million USD |
| 2005Q2 | -19.7 million USD | 10.6 million USD |
| 2005Q1 | -29.7 million USD | 7.4 million USD |
| 2004Q4 | -57.5 million USD | 11.4 million USD |
| 2004Q3 | -32.7 million USD | 9.1 million USD |
| 2004Q2 | -25.9 million USD | 9.8 million USD |
| 2004Q1 | -26.3 million USD | 12.3 million USD |
| 2003Q4 | -25.4 million USD | 9.7 million USD |
| 2003Q3 | -22.2 million USD | 11.3 million USD |
| 2003Q2 | -23.1 million USD | 15.0 million USD |
| 2003Q1 | -24.3 million USD | 14.0 million USD |
| 2002Q4 | -15.8 million USD | 21.9 million USD |
| 2002Q3 | -17.6 million USD | 20.3 million USD |
| 2002Q2 | -20.9 million USD | 20.1 million USD |
| 2002Q1 | -15.6 million USD | 21.7 million USD |
| 2001Q4 | -15.6 million USD | 21.7 million USD |
| 2001Q3 | -12.3 million USD | 19.3 million USD |
| 2001Q2 | -23.0 million USD | 7.6 million USD |
| 2001Q1 | -22.8 million USD | 4.6 million USD |
| 2000Q4 | -15.4 million USD | 7.9 million USD |
| 2000Q3 | -5.4 million USD | 18.3 million USD |
| 2000Q2 | -14.3 million USD | 7.0 million USD |
| 2000Q1 | -18.3 million USD | 4.1 million USD |
| 1999Q4 | -17.6 million USD | 9.5 million USD |
| 1999Q3 | -12.4 million USD | 10.6 million USD |
| 1999Q2 | -16.5 million USD | 7.2 million USD |
| 1999Q1 | -12.6 million USD | 6.6 million USD |
| 1998Q4 | -16.7 million USD | 7.6 million USD |
| 1998Q3 | -1.0 million USD | 19.8 million USD |
| 1998Q2 | -13.8 million USD | 5.8 million USD |
| 1998Q1 | -11.5 million USD | 5.8 million USD |
| 1997Q4 | -10.9 million USD | 9.4 million USD |
| 1997Q3 | -2.2 million USD | 12.6 million USD |
| 1997Q2 | -9.4 million USD | 5.8 million USD |
| 1997Q1 | -8.6 million USD | 4.6 million USD |
| 1996Q4 | -8.1 million USD | 6.4 million USD |
| 1996Q3 | -6.0 million USD | 5.1 million USD |
| 1996Q2 | -7.3 million USD | 4.7 million USD |
| 1996Q1 | -5.1 million USD | 6.4 million USD |
| 1995Q4 | -5.1 million USD | 3.4 million USD |
| 1995Q3 | -6.9 million USD | 3.7 million USD |
| 1995Q2 | -5.9 million USD | 3.3 million USD |
| 1995Q1 | -5.9 million USD | 2.6 million USD |
| 1994Q4 | -6.0 million USD | -2.0 million USD |
| 1994Q3 | -5.4 million USD | 3.2 million USD |
| 1994Q2 | -5.1 million USD | 3.1 million USD |
| 1994Q1 | -1.7 million USD | 2.6 million USD |
| 1993Q4 | -4.6 million USD | 2.9 million USD |
| 1993Q3 | -4.6 million USD | 3.3 million USD |
| 1993Q2 | -4.8 million USD | 3.2 million USD |
| 1993Q1 | -5.1 million USD | 2.7 million USD |
| 1992Q4 | -5.3 million USD | 600000 USD |
| 1992Q3 | -4.9 million USD | 3.3 million USD |
| 1992Q2 | -4.3 million USD | 2.3 million USD |
| 1992Q1 | -5.0 million USD | 2.5 million USD |
| 1991Q4 | -3.2 million USD | 800000 USD |
| 1991Q3 | -2.4 million USD | 2.0 million USD |
| 1991Q2 | -2.0 million USD | 1.5 million USD |
| 1991Q1 | -1.1 million USD | 1.5 million USD |
| 1990Q4 | ? USD | 500000 USD |
| 1990Q3 | ? USD | 500000 USD |
| 1990Q2 | ? USD | 500000 USD |
| 1990Q1 | ? USD | 500000 USD |
IONS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -366.3 million USD | 787.6 million USD |
| 2022 | -270.0 million USD | 587.0 million USD |
| 2021 | -29.0 million USD | 810.0 million USD |
| 2020 | -487.0 million USD | 729.0 million USD |
| 2019 | 294.0 million USD | 1.1 billion USD |
| 2018 | 273.7 million USD | 599.7 million USD |
| 2017 | -6.0 million USD | 507.7 million USD |
| 2016 | -86.6 million USD | 346.6 million USD |
| 2015 | -88.3 million USD | 283.7 million USD |
| 2014 | -39.0 million USD | 214.2 million USD |
| 2013 | -60.6 million USD | 147.3 million USD |
| 2012 | -65.5 million USD | 102.0 million USD |
| 2011 | -84.8 million USD | 99.1 million USD |
| 2010 | -61.3 million USD | 108.5 million USD |
| 2009 | 155.1 million USD | 121.6 million USD |
| 2008 | -12.0 million USD | 107.2 million USD |
| 2007 | -11.0 million USD | 69.6 million USD |
| 2006 | -45.9 million USD | 24.5 million USD |
| 2005 | -72.4 million USD | 40.1 million USD |
| 2004 | -142.5 million USD | 42.6 million USD |
| 2003 | -95.0 million USD | 50.0 million USD |
| 2002 | -72.2 million USD | 80.2 million USD |
| 2001 | -73.8 million USD | 53.3 million USD |
| 2000 | -53.5 million USD | 37.3 million USD |
| 1999 | -59.2 million USD | 33.9 million USD |
| 1998 | -43.0 million USD | 39.2 million USD |
| 1997 | -31.1 million USD | 32.5 million USD |
| 1996 | -26.5 million USD | 22.6 million USD |
| 1995 | -23.7 million USD | 13.0 million USD |
| 1994 | -18.2 million USD | 10.1 million USD |
| 1993 | -19.1 million USD | 12.1 million USD |
| 1992 | -19.5 million USD | 8.7 million USD |
| 1991 | -8.7 million USD | 6.3 million USD |
| 1990 | -4.5 million USD | 2.0 million USD |
IONS
Price: $41.97
52 week price:
Earnings Per Share: -2.51 USD
P/E Ratio: -17.41
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Ebitda: 9.5 millionMarket Capitalization: 6.2 billion